Life Science Tools Forum: Reshaping Industry Landscape in the Post-Pandemic Era

As a wave of innovative macromolecular drugs and novel therapeutic modalities—such as antibody-based therapeutics, cell therapies, and vaccines—transition from laboratory research to industrial-scale production, there has been a fragmented yet explosive surge in demand for biopharmaceutical manufacturing processes and scientific research services. Looking back at the three years of the pandemic, companies in the in vitro diagnostics (IVD) and life sciences sectors have encountered unprecedented development opportunities, leading to fundamental transformations in their trajectories and reshaping the industry landscape once again.

Against this backdrop, the 7th Future Healthcare Top 100 Conference, in collaboration with Matrix Partners China, co-hosted the Life Science Tools Forum. The forum invited industry experts, leading enterprises, and investment institutions to comprehensively explore current trends in the industry ecosystem from multiple perspectives. Centered on the theme of “Localization of Life Science Tools,” participants shared insights on “technological innovation” and “product innovation,” aiming to deepen academic exchange and cooperation in the fields of life sciences and public health, promote interdisciplinary integration, and foster collaboration across the upstream and downstream industrial chains.

2023 Future Healthcare Top 100 Conference, hosted by VB100, VCBeat, and Eggshell Research Institute, with strategic partnership support from Shanghai Zhangjiang Group, will be grandly held at the Shanghai Zhangjiang Science Hall from May 5–7, 2023. Led by Academician Robert Langer and IEEE scientists, nearly 500 industry luminaries will convene for three main forums and 31 hot-topic sessions!